石四药集团(02005.HK)维生素A棕榈酸酯获批准登记为上市制剂使用的原料药

Core Viewpoint - The company Shijiazhuang Pharmaceutical Group has received approval from the National Medical Products Administration of China for its Vitamin A Palmitate to be registered as an active pharmaceutical ingredient for use in marketed formulations [1] Group 1 - The approved Vitamin A Palmitate is primarily used in fat-soluble vitamin injection solutions to supplement vitamins [1]